spacer
home > ebr > summer 2002 > shayla walmsley's scrip report in delivering gene therapy - a review
PUBLICATIONS
European Biopharmaceutical Review

Shayla Walmsley's Scrip report in Delivering Gene Therapy - A Review

Delivering Gene Therapy begins with an introduction that ably sets the gene therapy scene. The recent history of M&A activity is dealt with in a concise manner while presenting the key underlying strategic strands. The technical difficulties of gene therapy safety are exposed early on in the report. The problem is one of the delivery of genes in a safe and controlled way that also enables these genes to be regulated. The advantages of viral and non-vector gene delivery systems are thoroughly examined and the report details experience to date that non-viral vectors have shown an inability to deliver workable quantities of genes to host cells. The use of encapsulated transfected cell systems is also included. The regulatory and safety climates for gene therapy are clearly stated. The regulatory concerns and issues concerning gene therapy are, by necessity, rapidly evolving and changing.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Keith Chidwick, Consultant at Technomark Consulting Services,
reviews Shayla Walmsley's Scrip report (1)

spacer
Keith Chidwick
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

TrialScope Announces Partnership with Greater Gift

JERSEY CITY, NJ May 14, 2019 TrialScope, the global leader in clinical trial transparency, disclosure compliance and patient engagement solutions, has partnered with Greater Gift to donate vaccines to children in need.
More info >>

White Papers

Clinical Trial Labelling More Than Just Labels

Faubel & Co. Nachfolger GmbH

Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement